WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM
Report
- Report Number
- 2124215-2024-44333
- Event Type
- Injury
- Date Received
- July 18, 2024
- Date of Event
- July 15, 2024
- Report Date
- July 29, 2024
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NGV
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CO, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
B5: INFORMATION ADDED. B7: INFORMATION ADDED.
IT WAS REPORTED THAT THROMBOSIS OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED AND A 35MM WATCHMAN FLX PRO CLOSURE DEVICE WAS IMPLANTED. THE PATIENT WAS PLACED ON ELIQUIS AND ASPIRIN ORAL ANTICOAGULANT (OAC) MEDICATION REGIMEN. AT THE 45 DAY ROUTINE FOLLOW UP, TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) REVEALED A DEVICE RELATED THROMBUS (DRT) ON THE THREADED INSERT OF THE CLOSURE DEVICE. THE PHYSICIANS PLACED THE PATIENT BACK ON ELIQUIS MEDICATION AND WILL DO A FOLLOW UP TEE IN THREE MONTHS IN RESPONSE TO THE DRT.
IT WAS REPORTED THAT THROMBOSIS OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED AND A 35MM WATCHMAN FLX PRO CLOSURE DEVICE WAS IMPLANTED. THE PATIENT WAS PLACED ON ELIQUIS AND ASPIRIN ORAL ANTICOAGULANT (OAC) MEDICATION REGIMEN. AT THE 45-DAY ROUTINE FOLLOW UP, TRANSESOPHAGEAL ECHOCARDIOGRAM (TEE) REVEALED A DEVICE RELATED THROMBUS (DRT) ON THE THREADED INSERT OF THE CLOSURE DEVICE. THE PHYSICIANS PLACED THE PATIENT BACK ON ELIQUIS MEDICATION AND WILL DO A FOLLOW UP TEE IN THREE MONTHS IN RESPONSE TO THE DRT. IT WAS FURTHER REPORTED THAT THE OAC REGIMEN CONSISTED OF PLAVIX AND ASPIRIN POST INDEX PROCEDURE, AND THE PATIENT REPORTED BEING COMPLIANT. THE DRT WAS LAMINAR IN NATURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1962089 | WATCHMAN FLX PRO LAA CLOSURE DEVICE WITH DELIVERY SYSTEM | SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL | NGV | BOSTON SCIENTIFIC CORPORATION | WS6035 | 0033704671 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 87 YR | Female | Required Intervention |